Contrast nephropathy in high-risk patients undergoing coronary angiography and intervention

Journal of the College of Physicians and Surgeons Pakistan

Volumn 15, Issue 12, 2005, Pages 791-794

  Uddin, Muhammad Azhar ^a   Rabbani, Malik Anas ^a   Jafary, Fahim H ^a   Bhatti, Maqsood Ahmed ^a   Islam, Muhammad ^a  

^a AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

Author keywords

Acute renal failure; Contrast induced nephropathy; Coronary angiography

Indexed keywords

CONTRAST MEDIUM; CREATININE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD; CHEMICALLY INDUCED DISORDER; COHORT ANALYSIS; FEMALE; HUMAN; INCIDENCE; KIDNEY DISEASE; MALE; MIDDLE AGED; RISK ASSESSMENT; TRANSLUMINAL CORONARY ANGIOPLASTY;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COHORT STUDIES; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; CREATININE; FEMALE; HUMANS; INCIDENCE; KIDNEY DISEASES; MALE; MIDDLE AGED; RISK ASSESSMENT;

EID: 33646849495     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Murphy SW, Barrett BJ, Parfrey PS. Contrast nephropathy. J Am Soc Nephrol 2000; 11: 177-82.
2. Mc Cullough PA, Wolyn R, Rocher LL, Levin RN, O'Neil WW. Acute renal failure after coronary intervention: incidence, risk factors and relationship to mortality. Am J Med 1997; 103: 368-75.
3. Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002; 105: 2259-64.
4. Allaqaband S, Tumuluri R, Malik AM, Gupta A, Volkert P, Shalev Y, et al. Prospective randomized controlled study of N-acetylcysteine, fenoldopam and saline for prevention of radiocontrast-induced nephropathy. Catheter Cardiovasc Interv 2002; 57: 279-83.
5. Katholi RE, Woods WTJr, Taylor GJ, Deitrick CL, Womack KA, Katholi CR, et al. Oxygen free radicals and contrast nephropathy. Am J Kidney Dis 1998; 32: 64-71.
6. Hizoh I, Haller C. Radiocontrast-Induced renal tubular cell apoptosis; hypertonic versus oxidative stress. Invest Radiol 2002; 37: 428-34.
7. Jafar TH, Jafary FH, Jessani S, Chaturvedi N. Heart disease epidemic in Pakistan: women and men at equal risk. Am Heart J 2005; 150: 221-6
8. IakovouI, Dangas G, Mehran R, Lansky AJ, Ashby DT, Fahy M, et al. Impact of gender on the incidence and outcome of contrastinduced nephropathy after percutaneous coronary intervention. J Invasive Cardiol 2003; 15: 18-22.
9. Gruberg L, Mintz GS, Mehran R, Gangas G, Lansky AJ, Kent KM, et al. The prognostic significance of further renal function deterioration within 48 hours of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 2000; 36: 1542-8.
10. Barrett BJ, Parfrey PS, Vavasour HM, McDonald J, Kent G, Hefferton D, et al. Contrast nephropathy in patients with impaired renal function: high versus low osmolar media. Kidney Int 1992; 41: 1274-9.
11. Manske CL, Sprafka JM, Strony JT, Wang Y. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med 1990; 89: 615-20.
12. Karie S, Launay-Vacher V, Izzedine H, Deray G. Is dialysis efficient in the prevention of ionic contrast agent-induced nephropathy? Presse Med 2005; 18:34 803-8.
13. Stevens MA, McCullough PA, Tobin KJ, Speck JP, Westveer DC, Guido-Allen DA, et al. A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the P.R.I.N.C.E. study: prevention of radiocontrast induced nephropathy clinical evaluation. J Am Coll Cardiol 1999; 33: 403-11.
14. Stone GW, McCullough PA, Tumlin JA, Lepor NE, Madyoon H, Murray P, et al. Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial. JAMA 2003; 290: 2284-91.
15. Huber W, Schipek C, Ilgmann K, Page M, Hennig M, Wacker A, et al. Effectiveness of theophylline prophylaxis of renal impairment after coronary angiography in patients with chronic renal insufficiency. Am J Cardiol 2003; 91: 1157-62.
16. Marenzi G, Marana I, Lauri G, Assanlli E, Grazi M, Campodonoico J, et al. The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. N Engl J Med 2003; 349:1333-40.
17. Goldenberg I, Matetzky S. Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies. CMAJ 2005; 172: 1461-71.
18. Mueller C, Buerkle G, Buettner HJ, Petersen J, Peruchoud AP, Erikson U, et al. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 2002; 162: 329-36.
19. Marten GJ, Burgess WP, Gray LV, Holleman JH, Roush TS, Kowalchuk GJ, et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 2004; 291: 2328-34.
20. Tepel M, van der Giet M, Schwarzfield C, Laufer U, Liermann D, Zidek W. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 2000; 343: 180-4.
21. Rainer B, Stefan K, Florian M, Peter S, Fokko J, Claude B. Acetylcysteine for prevention of contrast nephropathy: meta-analysis. Lancet 2003; 362: 598-603.
22. Taliercio CP, Vlietstra R, Fisher LD, Burnett JC. Risks of renal dysfunction with cardiac angiography. Ann Intern Med 1986; 104: 501-4.
23. Bakris GL, Lass N, Gaber AO, Jones JD, Burnett JC Jr. Radiocontrast-induced medium decline in renal function: a role for oxygen free radicals. Am J Physiol 1990; 258(1 pt 2): F115-F120.
24. Drager LF, Andrade L, Borros de Toledo JF, Laurindo FR, Machado Cesar LA, Seguro AC. Renal effects of N-acetylcysteine in patients at risk of contrast nephropathy: decrease in oxidant-stress mediated renal tubular injury. Nephrol Dial Transplant 2004; 19: 1803-7.